Science
Kennedy Turns to a Discredited Vaccine Skeptic for Autism Study
A steadfast figure in the anti-vaccine movement who has helped shape Health Secretary Robert F. Kennedy Jr.’s thinking on a possible link to autism has joined his department to work on a study examining the long-debunked theory, according to people familiar with the matter.
The new analyst, David Geier, has published numerous articles in the medical literature attempting to tie mercury in vaccines to autism. In 2012, state authorities in Maryland found that he had been practicing medicine without a license alongside his father, Mark Geier, who was a doctor at the time.
Maryland authorities also suspended Mark Geier’s medical license following claims that he endangered children with autism and exploited their parents, according to state records.
Federal judges have rejected their research on autism and vaccines as too unreliable to stand up in court.
David Geier’s new government role has stunned public health experts, who had already expressed concerns about Mr. Kennedy’s decisions to cancel a long-held vaccine meeting and to cut grants focused on understanding vaccine hesitancy.
In addition, David Geier’s involvement in government research heightens their fears that vaccine confidence could be further eroded, especially after Mr. Kennedy’s recent embrace of questionable alternative treatments for measles during the sprawling outbreak in Texas.
“If we increase vaccine hesitancy and immunization rates go down further, we will see more vaccine-preventable disease outbreaks,” said Dr. Christopher Beyrer, director of the Duke Global Health Institute. “That’s how it works.”
Several experts said that appointing David Geier to work on a study of vaccine safety preordains the outcome — like having a basketball referee show up in one team’s jersey.
“You’d think you’d want a fresh eye,” said Edward L. Hunter, a former head of the Washington office of the Centers for Disease Control and Prevention.
“This isn’t a fresh eye. They have already published their results, and spending all this time and money is not going to help anyone. I am quite certain they’ll come to the same conclusion.”
An official with Mr. Kennedy’s Department of Health and Human Services declined to comment. Two White House spokesmen did not respond to a request for comment. David Geier did not reply to emails or calls requesting comment.
Mary Holland, chief executive of Children’s Health Defense, the anti-vaccine nonprofit Mr. Kennedy ran until his presidential bid, praised David Geier on its website on Wednesday, describing him as “a brilliant, extremely knowledgeable researcher with deep expertise on mercury.”
(Over the weekend, federal officials ordered the nonprofit to remove a mock C.D.C. web page suggesting a link between vaccines and autism.)
David Geier is listed in the Department of Health and Human Services directory as a “senior data analyst.” News of his role in the agency was initially reported by The Washington Post.
Earlier this month, federal officials announced plans for a large study to re-examine whether there was a connection between vaccines and autism. Mr. Trump has voiced support for H.H.S. officials who wanted to revisit the issue, citing increases in autism diagnoses in children over the decades.
About 1 in 36 children have an autism diagnosis, according to C.D.C. data collected in 11 states, compared with 1 in 150 children in 2000.
Many scientists believe the rise is due in part to increased awareness of the disorder and changes in how it is diagnosed by medical professionals, though genetic and environmental factors could be playing a role as well.
The Senate confirmed Mr. Kennedy largely because he won over the chairman of the Senate health committee, Bill Cassidy, Republican of Louisiana, who is a medical doctor and strong proponent of childhood vaccines.
Mr. Cassidy has said that further research into any supposed link between vaccines and autism would be a waste of money and a distraction from studies that might shed light on the “true reason” for the rise in autism rates.
On Thursday, Mr. Cassidy said he wanted confirmation of David Geier’s role, aside from news reports. He mentioned that he had breakfast with Mr. Kennedy on Thursday but said the topic did not come up.
At one of his confirmation hearings, Mr. Kennedy shot back at Mr. Cassidy, citing a study from an ecosystem of vaccine critics that he said proved a connection between vaccines and autism.
David Geier comes from a similar circle of researchers. Along with his father, he played a formative role in Mr. Kennedy’s thinking.
Mr. Kennedy interviewed David Geier for an essay in 2005, “Tobacco Science and the Thimerosal Scandal,” in which he accused the C.D.C. of deliberately hiding vaccine data, under chapter headings like “Conspiracy” and “The Cover-Up.”
Mr. Kennedy described the Geiers’ belief that thimerosal, a mercury-containing preservative used in some vaccines, was linked to childhood autism. The preservative has since been removed from most childhood vaccines but is still used in some flu shots.
In a Rolling Stone article called “Deadly Immunity,” Mr. Kennedy credited the Geiers with being among the few who had gained access to C.D.C. vaccine data, which he said they used to “demonstrate a powerful correlation between thimerosal and neurological damage in children.” (The magazine later withdrew the article, but did not elaborate.)
Almost a decade later, in Mr. Kennedy’s book, “Thimerosal: Let The Science Speak,” he paid homage to the Geiers, mentioning them nearly 250 times. He called them a “father-and-son team of independent medical researchers” who had “published extensively on the topic of thimerosal and its potential link to neurodevelopmental disorders, particularly autism.”
Mr. Kennedy acknowledged that the two had become “lightning rods of controversy in the vaccine safety debate.”
“The Geiers have published no fewer than thirteen epidemiological studies of the associations between Thimerosal and health effects in U.S. populations, employing accepted statistical practices,” Mr. Kennedy wrote in the book.
On a podcast in 2022, Mr. Kennedy credited the Geiers’ research for showing that vaccines “had nothing to do with” a decline in infectious diseases over decades. “It was all an illusion,” Mr. Kennedy said, attributing the decrease to improving sanitation and nutrition.
The Geiers’ work has been repeatedly discredited by other scientists and federal court decisions.
An extensive review of the purported link between vaccines and autism in 2004 by the Institute of Medicine, an elite group of doctors and researchers, panned the Geiers’ studies. The review found their work to be marred by flaws “making their results uninterpretable.”
The institute’s report on a connection with the measles shots said: “The committee concludes that the evidence favor rejection of a causal relationship between M.M.R. vaccine and autism.”
In 2011, the Maryland Medical Board accused David Geier of practicing medicine without a license alongside his father at a Rockville, Md., clinic for children with autism.
One mother of a 10-year-old boy with autism balked when David Geier reportedly ordered 24 different blood tests for her son.
His father, Mark Geier, lost his medical license in 2012. Records in that case indicate that both father and son promoted a theory that thimerosal caused autism.
State authorities found that the Geiers had offered treatment with puberty-blocking drugs. To some patients, they offered chelation, a procedure to remove heavy metals from the blood, records show. David Geier was assessed a $10,000 fine.
Judges have rejected the Geiers’ efforts to serve as experts on vaccine safety in court. Records show that judges challenged the father-son team’s billings for hundreds of thousands of dollars related to services they provided as experts for a specialized vaccine injury court.
The judges cited David Geier’s lack of qualifications, which include a bachelor’s degree in biology, and raised concerns about his father’s credibility.
Judge George L. Hastings Jr. said in 2016 that David Geier was not qualified to render an expert opinion in a National Vaccine Injury Compensation court case.
Judge Hastings said his report “is neither useful nor relevant, because he is not qualified as an expert concerning the matters he discusses.”
In a review of two Geier studies this week, Jeffrey S. Morris, director of the division of biostatistics at the University of Pennsylvania, said he found what appeared to be a numerical sleight of hand that made it appear that vaccines caused a spike in autism.
“When I look at these two studies, they are so fatally flawed that I have serious concerns that any study that they’re going to design is going” to be rigorous enough, he said, “to yield valid results.”
To Mr. Hunter, formerly of the C.D.C., the decision to spend federal funds on a new study of a debunked theory would come at the cost of a meaningful discovery.
Since he became health secretary, Mr. Kennedy has presided over cutbacks involving research into nearly every aspect of health care and diseases. On Thursday, he announced a massive reorganization and reduction in the work force from 82,000 to 62,000.
“To me, the big shame is that with budget cuts, we are not ramping up research into what is actually causing autism,” Mr. Hunter said. “And if you are worried about vaccine-preventable disease, this is such a clear setback.”
Michael Gold contributed reporting from Washington. Alain Delaquérière contributed research. Jeremy Singer-Vine provided data analysis.
Science
This Cell Feeds, Grows and Reproduces. And It’s Manmade.
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of ingredients, the researchers have synthesized simple cells that feed, grow, reproduce and compete with one another for food. If these cells are not yet fully alive, they have most of the hallmarks of life.
“Life is not binary,” said Kate Adamala, a synthetic biologist who led the research. “That’s why I’m hesitant to call this ‘alive.’ There’s no clear line, as much as we would love it to be.”
Until now, scientists had never mastered the recipe for a cell that can perform so many functions, said John Glass, a synthetic biologist at the J. Craig Venter Institute in La Jolla, Calif., who was not involved in the study.
“It is dazzling that she has put these things all together,” he said.
Drew Endy, a synthetic biologist at Stanford University, said, “It’s a cell that was built, not born. It’s constructed, but it does what cells do.”
Dr. Adamala named her creation SpudCell, after its potato-like appearance. Rather than patent it, she and Dr. Endy are organizing a community of scientists to focus on making SpudCells more fully alive and adapting them to new kinds of experiments.
They and their colleagues have founded a nonprofit research organization that Dr. Endy estimates will spend hundreds of millions of dollars on the effort in the next decade. Hundreds of scientists are expected to join.
“We’re going to remember this moment,” said Roseanna Zia, a computational biologist at the University of Missouri who was not involved in the project.
Dr. Adamala and her colleagues posted a 190-page account of their work online. The research is under review for publication in a scientific journal.
Scientists hope synthetic cells can tell them things about life that natural cells cannot, including such basic questions as how many genes are necessary for a minimal form of life.
But synthetic cells also might someday be engineered to do things that natural cells can’t, like making new kinds of medicine or drawing large amounts of carbon dioxide from the atmosphere. In theory, engineered SpudCells might produce a vast range of proteins that natural cells cannot be coaxed to make, or even toxic chemicals like rocket fuel.
Now, “we can think about doing chemistry that we’re barely getting our heads around,” Dr. Glass said.
The trouble with life as we know it: mysterious, messy complexity. Our own DNA contains tens of thousands of genes, as well as millions of molecular switches turning those genes on and off. Scientists barely have a clue as to what many of those pieces of DNA are doing. Often a gene that they think they understand turns out to be performing other jobs than scientists expected.
One way to sidestep this intricacy is to simplify.
In the 1990s, a team led by the late biologist Craig Venter began studying a microbe that had fewer than 1,000 genes. The team, now led by Dr. Glass, went on to strip the microbe’s genome down to 525 essential genes.
In a 2016 paper, the team reported it didn’t know what a third of those genes were doing. Dr. Glass and his colleagues have spent the last decade trying to solve the puzzle, and they still can’t say what 56 of them do.
“There are still significant tasks that every cell has to do that we don’t know,” Dr. Glass said.
Other researchers tackled the problem from the opposite direction. Instead of working from the top down, they moved from the bottom up, seeking to combine lifeless molecules to produce a living cell.
Since the 1990s, several labs have bitten off small pieces of this problem. Some of them have perfected recipes to make hollow bubbles from oily molecules. Others have found ways to encapsulate simple genetic molecules inside those bubbles.
But scientists struggled to put these pieces together into more complex systems, let alone something that could be called a cell.
In recent years, Dr. Adamala took on one of the fundamental challenges: cell division. A natural cell divides with the help of proteins that lock together into a ring anchored to its inner wall. The ring winds itself tighter, pinching the cell in two.
Other proteins act like winches, moving DNA and other molecules into the forming cells, so that they have the ingredients necessary to keep living.
At first, Dr. Adamala tried building a simpler version of the natural system. But then she decided not to mimic real cells at all.
Biophysicists had found that if they stuck proteins on a membrane, they created pressure that made the membrane bend. Dr. Adamala and her team created bubbles that could snag proteins floating around them. When a bubble collected enough proteins, its surface began bending inward until it popped in two.
While the idea was simple, getting it to work in the lab required a year of experiments. “But once it works, it works,” Dr. Adamala said.
That success prompted the team to try to build a synthetic cell in its entirety.
The first step was to create a broth of the molecules necessary for a cell to operate. The recipe ultimately included about a hundred kinds of proteins and simple molecules required for crucial chemical reactions, such as making new proteins from genes.
The researchers also provided their synthetic cell with genes borrowed from a virus and the ubiquitous microbe Escherichia coli. They picked 36 genes for basic jobs like copying DNA.
After mixing these ingredients together into a soup, the scientists added the building blocks of membranes. They spontaneously joined together into bubbles, each engulfing some of the soup.
Many of these bubbles ended up encasing the right mix of genes, proteins and other molecules, and they started carrying out the chemical reactions seen in real cells.
As the new cells floated in flasks, Dr. Adamala and her colleagues added food. The cells slurped up small molecules through channels on their surfaces.
The scientists also put in small bubbles loaded with proteins and other molecules that were too big to fit through the channels. By bumping and fusing into one of these bubbles, the cell could feed on the treats inside.
As the cells fed, they grew. And in just a few hours, they were big enough to divide.
The scientists added a special protein to the flasks, which latched onto the surface of the cells and forced them to bend inward. Once the cells split in two, the pair of new cells kept growing.
Now the SpudCells grew, fed and reproduced. As it turned out, the cells even had a rudimentary ability to evolve.
Dr. Adamala and her colleagues created a mutant version that bound more tightly to the snack-filled bubbles floating around it. To test it, they created a 50-50 mixture of original and mutant SpudCells.
The cells competed for five generations for food. Eventually the mutants outnumbered the originals, suggesting that they were outcompeting the originals for food.
“That’s the shake-the-ground accomplishment here,” said Dr. Zia. Scientists will be able to put various synthetic cells in competition with one another and rapidly develop more sophisticated ones.
For all this evidence of life, SpudCell still has some major shortcomings. For starters, it can’t make the molecular factory that produces new proteins, called a ribosome. The cells can carry all the genes they need to build ribosomes, but for some reason the parts don’t come together.
For now, Dr. Adamala and her colleagues have to feed ready-made ribosomes to SpudCells. This solution has an expiration date, though: SpudCells can keep making proteins through five to 10 generations before they fail as their ribosomes become defective.
“I don’t want to say it dies, but it stops working,” Dr. Adamala said.
When Dr. Adamala showed SpudCell to Dr. Endy last year, he was so awestruck that he decided to help her found Biotic, the nonprofit organization intended to create a community of SpudCell researchers.
“I’m pouring my life’s work into this,” Dr. Endy said. One of the first tasks for Biotic will be to make it easier for other scientists to create SpudCells.
Dr. Adamala can create a fresh batch of them in her own lab in about a day. But that’s only because she has freezers full of purified proteins and an intimate understanding of each step of her recipe. Biotic expects to offer scientists easier recipes and provide the required ingredients.
Dr. Endy hopes that the open-source tools will encourage scientists to collaborate on building new kinds of SpudCells with more of the defining features of life, such as the ability to make their own ribosomes and to divide indefinitely.
“It’s completely doable,” said Dr. Glass.
Biotic researchers are already planning their first meeting, in September in Philadelphia. High on their list of priorities will be formalizing plans to safeguard this area of research.
For now, the synthetic cell can only survive a few generations on a special lab diet. But future versions may be more robust, raising the possibility that someone might someday use SpudCells unethically, perhaps even to make a weapon.
Dr. Endy argues that an open-source research community will be better prepared to prevent that from happening. “We can have these conversations now, as opposed to waiting for somebody else to do it, and then we’re just all reacting,” he said.
Dr. Endy likens SpudCells to a biological version of the Wright flyer, the crude plane that the Wright Brothers used to make the first sustained controlled flight in 1903, ushering in the age of airplanes.
“The Wright flyer flying for 12 seconds doesn’t get you a 737,” Dr. Endy said. “This is just the beginning.”
Science
After bold pledge, EPA shelves microplastics testing in U.S. drinking water
For the next five years, the Environmental Protection Agency has indicated it will not require public water utilities to test for microplastics or pharmaceuticals in drinking water, according to a proposed rule published in the Federal Register.
On Friday, the EPA submitted a list of chemicals it plans to test for under the Unregulated Contaminant Monitoring Rule, a mandatory testing program used to collect information about concerning chemicals in drinking water that could be harming human health. It did not include microplastics or pharmaceuticals.
The omissions come after announcements by EPA Administrator Lee Zeldin earlier this year that his agency was designating microplastics and pharmaceuticals priority contaminants for testing.
“This is a direct response to the concern of millions of Americans who have long demanded answers about what they and their families are drinking every day,” he said at an April news conference with Health and Human Secretary Robert F. Kennedy Jr. at EPA headquarters.
Zeldin’s announcement was seen at the time as a move to placate the increasingly disgruntled Make America Healthy Again contingent of Trump supporters.
Now the agency says it has no validated or standardized method to test for the plastic particles in drinking water, and wouldn’t be able to develop one before December, when testing is required to begin.
Among the 33 chemicals the EPA will require water utilities to test for are seven PFAS, or forever chemicals, and three pesticide residues.
It will be five years before the EPA proposes another list.
The EPA did not respond to a request for comment.
The agency noted in its proposed rule that it will collaborate with other federal agencies to “evaluate risks and exposures” of microplastics for future monitoring.
Environmentalists reacted with frustration and resignation. They pointed out that the European Union has developed methods to test for the tiny plastic particles, which have been found in people’s blood, brains and lung tissue. California has one in the works.
“The California water board has spent a lot of time and money on how to measure in drinking water,” said Judith Enck, a former EPA regional administrator and president of the anti-plastic environmental group Beyond Plastics. “EPA should give them a call.”
California was required by a 2018 state law to establish a protocol for local water utilities to test for the particles in drinking water. The state has not yet begun reporting its results, but protocols were established in 2021. Blair Robertson, a spokesman for the State Water Resources Control Board, said it’s not “a fully validated, end-to-end regulatory method” yet.
At the April meeting, Zeldin announced that he would place microplastics on what is known as the Contaminant Candidate List, which acts as a preliminary “watch list” of unregulated, priority contaminants in drinking water. Like the mandatory monitoring list, it is updated only every five years. The most recent list was published on April 2 — the day he made his announcement.
“Americans have been ignored as they sound the alarm about plastics in their drinking water,” Zeldin said during the announcement. “That ends today by placing microplastics on the contaminant candidate list for the first time ever. EPA will follow the science, will pursue answers and will hold ourselves to the highest standards to protect the health of Americans.”
There appears to be no clear association between these two lists, although the contaminant list is supposed to inform the monitoring list. Seventy-five chemicals and four chemical groups (microplastics, pharmaceuticals, PFAS chemicals, and disinfection byproducts) were listed on the 2026 contaminant list. Only seven of those chemicals were also on the proposed monitoring list (as well as seven PFAS chemicals).
When Zeldin announced microplastics as “‘a priority contaminant for regulation,’ and called it ‘a historic action on microplastics,’ he made it seem like the administration was going to take microplastics seriously,” said Mary Grant, water policy director for the environmental group Food & Water Watch.
“By not including them, they made it clear they don’t actually have plans to immediately address this crisis by getting the real-world monitoring data that we need right now to really start correcting ourselves,” she said.
Craig Davis, senior director of plastics chemistry at the American Chemistry Council — the nation’s largest trade group for chemical companies — said that while his organization supports microplastic research, it also agrees with the EPA’s decision not to include them in the monitoring list.
“National drinking water monitoring should be based on validated, standardized methods that can produce reliable and comparable data,” said Davis in a statement. He said “limited” national monitoring resources should be focused where data can produce “actionable public health information.”
The public has 60 days to comment once the plan is published in the Federal Register.
Science
Hospital visits for smoke inhalation spiked during Boyle Heights warehouse fire
The number of Angelenos who went to the hospital with throat pain and concerns about smoke inhalation spiked as a fire burned through the massive Lineage cold storage warehouse in Boyle Heights this month, The Times has learned.
The blaze burned for eight days beginning June 17 and involved solar panels, insulation foam and other industrial materials.
During that time, more than three times as many people went to emergency departments within 10 miles of the warehouse mentioning the fire or smoke inhalation compared with the two weeks prior, according to data from the Los Angeles County Department of Public Health obtained through a public records request.
The agency also noted a near doubling of patients mentioning throat pain within five miles of the fire June 21 — 1.9 times the baseline levels.
Usually, fewer than 50 people go to the emergency room each day for throat pain, and fewer than 20 people for smoke inhalation, the department said.
The hospitalization data was tracked through the department’s syndromic surveillance project, which monitors trends in what people report when they come to emergency departments in L.A. County, as well as diagnosis codes noted by providers. The system is not as comprehensive as full patient health records, and clinicians may not always include key words about “fire,” “smoke” or other circumstantial information in their diagnoses, the public health department said.
As such, it “cannot capture the true number of [emergency department] visits related to symptoms from the fire and likely underestimates the true burden of fire related symptoms,” the department said.
Perhaps unexpectedly, the department said it did not note a substantial increase in asthma, acute respiratory symptoms or chronic obstructive pulmonary disease-related emergency department visits during the fire.
But even these preliminary findings are concerning, experts said. The fire is believed to have started on the solar array on the roof of the 500,000 square-foot building, which housed 85 million pounds of frozen food. It then reached an ammonia line, prompting two brief shelter-in-place orders for nearby residents.
Over the next week, the fire continued to burn through dense insulation foam within the building’s walls and other unknown industrial materials, blanketing much of L.A. in acrid smoke. Residents in downtown L.A., northeast L.A., Burbank, the San Gabriel Valley and many other parts of the city and county reported seeing and smelling the fumes.
The South Coast Air Quality Management District issued multiple warnings about unhealthy levels of PM 2.5, or fine particulate matter. The city and county opened two smoke respite shelters in the immediate area so that people could breath cleaner air.
It is still unclear what exactly was in the smoke that people breathed in. Industrial fires release far more materials than the burned wood smoke that is emitted during wildfires.
“The makeup of the smoke can include toxic chemicals, fine particles and other serious risks to lung health depending on fire conditions and what is burned,” Will Barrett, assistant vice president for nationwide clean air policy at the American Lung Assn., said as the fire was burning. Children and elderly people are particularly at risk.
David Eisenman, director of the UCLA Center for Public Health and Disasters, said urban industrial fires also can represent a hazard that standard PM 2.5 warnings don’t always address. Those advisories are “blunt instruments” that don’t adequately capture emissions from burning man-made goods — or convey that the source of pollution may include burning batteries or toxic refrigerants, he said.
The fact that initial numbers don’t show a spike in asthma attacks is “somewhat reassuring,” Eisenman said. But “people may have gone to their primary care doctors, which this would not capture. This data deserves follow up.”
The air district and the U.S. Environmental Protection Agency deployed air monitors to assess particulate matter, airborne toxic metals and other harmful compounds during the early days of the blaze. The air district said it didn’t find significant levels of air toxics during the first two days of the fire, although it did record significantly elevated concentrations of particulate matter within the plume downwind.
Some of the measurements it took with mobile monitors, which are five-minute snapshots, also showed increased bromine and chlorine, which often are found when buildings burn and were at levels “below short-term health-based exposure thresholds,” the air district said. It began continuous PM 2.5. monitoring at two nearby elementary schools on the third day.
The L.A. Fire Department said it detected low-levels of toxic hydrogen fluoride on the second day of the fire, which can be a byproduct of burning lithium-ion batteries.
Lineage, the tenant-operator of the warehouse, said no concentrations of ammonia were detected in the air at any time.
“There’s no doubt this fire has had a huge impact on the local community, and we are committed to showing up in every way we can,” company officials wrote in a statement last week. They said Lineage worked closely with the Fire Department during the blaze and delivered masks, air purifiers and other supplies to the community, and will work to ensure the fastest cleanup possible.
The long-term health effects of the fire and its smoke probably won’t be known unless researchers conduct a follow-up study, said Eisenman of UCLA.
For example, there may have been delayed pulmonary effects from the hydrogen fluoride and burning insulation foam that — when combined with the elevated PM 2.5 levels in a dense urban environment — produced health effects that didn’t show up in the emergency room data.
“They will show up in increased primary care office visits and exacerbations of chronic disease over the next few weeks,” he said. “So from a public health standpoint, this fire is not over.”
-
Seattle, WA5 minutes agoResidents and activists clash over plan to curb SEPA appeals at Seattle hearing
-
San Diego, CA7 minutes agoSan Diego family celebrates UCSD graduation amid ICE fears
-
Milwaukee, WI13 minutes agoICE enforcement in Milwaukee, city accuses feds of violating ordinance
-
Atlanta, GA19 minutes agoSevere Thunderstorm Warnings issued for North Georgia, metro Atlanta
-
Minneapolis, MN23 minutes agoMinneapolis closes three beaches ahead of 4th of July weekend due to high e. coli levels
-
Indianapolis, IN28 minutes agoIndianapolis leaders provide public safety update ahead of Fourth Fest
-
Pittsburg, PA35 minutes agoPittsburgh’s Fort Pitt Museum reveals roots of Independence Day
-
Augusta, GA37 minutes agoAugusta’s new arena reaches major construction milestone